Product
Anti-STEAP1 CAR T-cells
1 clinical trial
2 indications
Indication
Castration-Resistant Prostate CarcinomaIndication
Prostate CancerClinical trial
Phase 1/2 Dose-Escalation and Cohort Study of STEAP1 CART With Enzalutamide in Participants With mCRPCStatus: Not yet recruiting, Estimated PCD: 2027-03-30